| Ball, Edward |
NCT01656603: Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation |
|
|
| Recruiting | 2 | 9999 | US | unlicensed CBU | New York Blood Center | Infusion Reactions | 12/25 | 12/25 | | |
| Active, not recruiting | 1/2 | 6 | US | CTNS-RD-04 or CTNS-RD-04-LB (where the suffix "-LB" stands for LentiBOOST) | University of California, San Diego, California Institute for Regenerative Medicine (CIRM), Cystinosis Research Foundation | Lysosomal Storage Diseases, Cystinosis | 11/24 | 11/24 | | |
NCT01351545: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) |
|
|
| Recruiting | N/A | 99999 | US | A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) | Center for International Blood and Marrow Transplant Research, National Marrow Donor Program | Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets, Histiocytic Disorders, Acute Myelogenous Leukemia (AML or ANLL), Acute Lymphoblastic Leukemia (ALL), Other Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases, Other Leukemia, Hodgkin Lymphoma, Non-hodgkin Lymphoma, Multiple Myeloma/ Plasma Cell Disorder (PCD), Inherited Abnormalities of Erythrocyte Differentiation or Function, Disorders of the Immune System, Autoimmune Diseases, Severe Aplastic Anemia | 10/41 | 10/41 | | |
| Kipps, Thomas J |
NCT01199575: Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) |
|
|
| Completed | 2 | 30 | US | Revlimid, lenalidomide, Rituximab, Rituxan | University of California, San Diego, Celgene Corporation | Chronic Lymphocytic Leukemia, CLL | 01/15 | 07/22 | | |
NCT02315768: Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients. |
|
|
| Active, not recruiting | 1/2 | 32 | US | GA101, Obinutuzumab, ibrutinib | University of California, San Diego, Pharmacyclics LLC. | Chronic Lymphocytic Leukemia | 11/23 | 11/23 | | |
TRANSCEND-CLL-004, NCT03331198: Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) |
|
|
| Recruiting | 1/2 | 320 | Canada, US | JCAR017 (lisocabtagene maraleucel), JCAR017 (lisocabtagene maraleucel) + ibrutinib, JCAR017 (lisocabtagene maraleucel) + venetoclax | Juno Therapeutics, a Subsidiary of Celgene | Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Small Lymphocytic | 11/27 | 11/27 | | |
|
|
|
|
|
| Kim, Jane J |
| Recruiting | N/A | 200 | US | Dexcom continuous glucose monitor | University of California, San Diego, DexCom, Inc. | Neonatal Hypoglycemia | 12/24 | 12/24 | | |
| Birgersdotter-Green, Ulrika |
| Active, not recruiting | N/A | 150 | US | Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device | Abbott Medical Devices | Atrial Fibrillation Paroxysmal, Atrial Fibrillation, Persistent, Cardiac Arrhythmia, Ablation | 12/24 | 12/25 | | |
| Gabriel, Rodney A |
NCT05814016: A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery |
|
|
| Terminated | 2 | 41 | US | Danavorexton, TAK-925, Placebo | Takeda | Sleep Apnea | 09/24 | 09/24 | | |
NCT04967352: Predicting Chronic Pain Following Breast Surgery |
|
|
| Recruiting | N/A | 500 | US | | University of California, San Diego | Chronic Pain, Opioid Use, Breast Pain, Breast Cancer | 07/23 | 12/23 | | |
NCT04974463: Predicting Chronic Opioid Use Following Lower Extremity Joint Arthroplasty |
|
|
| Recruiting | N/A | 1000 | US | | University of California, San Diego | Joint Pain, Chronic Pain, Opioid Use | 10/23 | 12/23 | | |
NCT06540105: Leveraging Artificial Intelligence and Multi-Omics Data to Predict Opioid Addiction |
|
|
| Recruiting | N/A | 300 | US | | University of California, San Diego, VA Palo Alto Health Care System, San Diego Veterans Healthcare System | Opioid Use Disorder, Addiction, Opioid | 06/27 | 09/27 | | |
NCT06071715: Cryoanalgesia to Treat Phantom Limb Pain Following Above-Knee Amputation |
|
|
| Active, not recruiting | N/A | 12 | US | ACTIVE cryoneurolysis, cryoablation, SHAM cryoneurolysis, sham cryoablation | University of California, San Diego, Varian Medical Systems | Amputation, Surgical, Amputation, Traumatic, Phantom Limb Pain, Phantom Pain Following Amputation of Lower Limb | 11/24 | 10/25 | | |
NCT05304403: The Association of Microbiome Patterns With Chronic Opioid Use |
|
|
| Recruiting | N/A | 100 | US | | University of California, San Diego | Chronic Pain, Opioid Use | 12/24 | 06/25 | | |
NCT06646731: Cryoneurolysis for Painful Diabetic Neuropathy of the Foot |
|
|
| Not yet recruiting | N/A | 30 | US | cryoneurolysis, sham cryoneurolysis | University of California, San Diego | Painful Diabetic Peripheral Neuropathy (PDPN) | 12/25 | 06/26 | | |
| Stanley, Valentina |
| Recruiting | N/A | 200 | US | Dexcom continuous glucose monitor | University of California, San Diego, DexCom, Inc. | Neonatal Hypoglycemia | 12/24 | 12/24 | | |
